Charles Schwab’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.49M Buy
157,135
+3,779
+2% +$83.9K ﹤0.01% 2482
2025
Q1
$2.85M Sell
153,356
-12,698
-8% -$236K ﹤0.01% 2503
2024
Q4
$2.2M Buy
166,054
+5,733
+4% +$75.9K ﹤0.01% 2649
2024
Q3
$5.37M Buy
160,321
+5,043
+3% +$169K ﹤0.01% 2339
2024
Q2
$3.89M Buy
155,278
+9,007
+6% +$226K ﹤0.01% 2456
2024
Q1
$3.29M Buy
146,271
+1,451
+1% +$32.7K ﹤0.01% 2441
2023
Q4
$3.1M Buy
144,820
+1,809
+1% +$38.7K ﹤0.01% 2496
2023
Q3
$2.57M Buy
143,011
+3,399
+2% +$61K ﹤0.01% 2522
2023
Q2
$2.84M Sell
139,612
-9,774
-7% -$199K ﹤0.01% 2443
2023
Q1
$3.25M Buy
149,386
+555
+0.4% +$12.1K ﹤0.01% 2381
2022
Q4
$4.61M Buy
148,831
+3,343
+2% +$104K ﹤0.01% 2254
2022
Q3
$3.71M Buy
145,488
+3,087
+2% +$78.8K ﹤0.01% 2377
2022
Q2
$2.89M Buy
142,401
+270
+0.2% +$5.48K ﹤0.01% 2435
2022
Q1
$3.52M Buy
142,131
+5,819
+4% +$144K ﹤0.01% 2448
2021
Q4
$4.74M Buy
136,312
+674
+0.5% +$23.4K ﹤0.01% 2374
2021
Q3
$3.68M Sell
135,638
-7,189
-5% -$195K ﹤0.01% 2516
2021
Q2
$3.7M Buy
142,827
+7,095
+5% +$184K ﹤0.01% 2491
2021
Q1
$2.93M Sell
135,732
-6,657
-5% -$144K ﹤0.01% 2540
2020
Q4
$3.06M Buy
142,389
+1,056
+0.7% +$22.7K ﹤0.01% 2454
2020
Q3
$2.09M Sell
141,333
-14,139
-9% -$209K ﹤0.01% 2481
2020
Q2
$3.47M Buy
155,472
+3,111
+2% +$69.5K ﹤0.01% 2197
2020
Q1
$2.15M Buy
152,361
+3,176
+2% +$44.9K ﹤0.01% 2246
2019
Q4
$2.43M Buy
149,185
+2,617
+2% +$42.5K ﹤0.01% 2360
2019
Q3
$5.13M Buy
146,568
+7,412
+5% +$259K ﹤0.01% 1941
2019
Q2
$7.85M Buy
139,156
+11,108
+9% +$627K ﹤0.01% 1742
2019
Q1
$9.35M Buy
128,048
+4,788
+4% +$350K 0.01% 1641
2018
Q4
$7.86M Buy
123,260
+13,272
+12% +$847K 0.01% 1618
2018
Q3
$11M Buy
109,988
+25,646
+30% +$2.56M 0.01% 1573
2018
Q2
$5.99M Buy
84,342
+5,067
+6% +$360K ﹤0.01% 1909
2018
Q1
$8.25M Buy
79,275
+4,335
+6% +$451K 0.01% 1635
2017
Q4
$7.55M Buy
74,940
+42,094
+128% +$4.24M 0.01% 1665
2017
Q3
$1.15M Buy
32,846
+13,444
+69% +$470K ﹤0.01% 2468
2017
Q2
$465K Buy
19,402
+9,414
+94% +$226K ﹤0.01% 2718
2017
Q1
$278K Buy
+9,988
New +$278K ﹤0.01% 2841